News & Views
-
by Nicolas Hulscher, MPH A newly published registry-based cohort study has reported higher rates of certain congenital anomalies among babies born to mothers who received a COVID-19 vaccine during the first trimester of pregnancy. They analyzed 1,352…
-
The post The Story the Media — and the Government — Don’t Want You to Hear appeared first on Children’s Health Defense. IPAK-EDU is grateful to The Defender as this piece was originally published there and…
-
I just went for a long walk in London to visit a few key places in the advancement of medical knowledge. Chat GPT drew the following map for me. I started at St. Mary’s Hospital. On Sept.…
-
By Beyond Pesticides A study out of Michigan State University reviews robust county-level data on pesticide use and breast cancer incidence rates, determining that there are “modest positive associations” in rural counties in the U.S. The findings…
-
Originally published by A Voice For Choice Advocacy on June 18, 2026. EDITOR’S SUMMARY: Alzheimer’s, Parkinson’s and ALS are widely assumed to be genetically driven—but genes account for only a minority of cases. Environmental and lifestyle factors…
-
In this issue of The Misesian, we continue our Year of Rothbard with a new essay from Joseph Salerno on what made Rothbard’s work in Austrian economics so notable. Rothbard took the inimitable work of Mises, as…
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”
Most Read
